Innovative Eyewear (NASDAQ:LUCY – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare Innovative Eyewear to related companies based on the strength of its profitability, risk, dividends, earnings, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Innovative Eyewear and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
| Innovative Eyewear Competitors | 4266 | 10522 | 18282 | 825 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.33%. Given Innovative Eyewear’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Innovative Eyewear has less favorable growth aspects than its rivals.
Profitability
This table compares Innovative Eyewear and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
| Innovative Eyewear Competitors | -276.78% | -149.08% | -21.73% |
Institutional and Insider Ownership
1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.8% of Innovative Eyewear shares are held by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Innovative Eyewear and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Innovative Eyewear | $2.66 million | -$7.59 million | -0.64 |
| Innovative Eyewear Competitors | $1.89 billion | $138.76 million | 9.95 |
Innovative Eyewear’s rivals have higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
Innovative Eyewear has a beta of 2.75, suggesting that its stock price is 175% more volatile than the S&P 500. Comparatively, Innovative Eyewear’s rivals have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.
Summary
Innovative Eyewear rivals beat Innovative Eyewear on 9 of the 12 factors compared.
Innovative Eyewear Company Profile
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.
